循环肿瘤细胞检测技术的现状和发展思考

doi:10.16150/j.1671-2870.2018.02.002

摘要/Abstract

中图分类号:

R730.43

蔡贞, 郑磊. 循环肿瘤细胞检测技术的现状和发展思考[J]. 诊断学理论与实践, 2018, 17(02): 132-135.

[1] Lianidou ES, Strati A, Markou A.Circulating tumor cells as promising novel biomarkers in solid cancers[J]. Crit Rev Clin Lab Sci,2014,51(3):160-171.
[2] Yang MH, Imrali A, Heeschen C.Circulating cancer stem cells: the importance to select[J]. Chin J Cancer Res,2015,27(5):437-449.
[3] Hyun KA, Kim J, Gwak H, et al.Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics[J]. Analyst,2016,141(2):382-392.
[4] Liu JF, Kindelberger D, Doyle C, et al.Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients[J]. Gynecol Oncol,2013, 131(2):352-356.
[5] Chaffer CL, Weinberg RA.A perspective on cancer cell metastasis[J]. Science,2011,331(6024):1559-1564.
[6] Gradilone A, Raimondi C, Nicolazzo C, et al.Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal[J]. J Cell Mol Med,2011, 15(5):1066-1070.
[7] Raimondi C, Gradilone A, Naso G, et al.Clinical utility of circulating tumor cell counting through CellSearch: the dilemma of a concept suspended in Limbo[J]. Onco Targets Ther,2014,7:619-625.
[8] Harouaka RA, Nisic M, Zheng SY.Circulating tumor cell enrichment based on physical properties[J]. J Lab Autom,2013,18(6):455-468.
[9] Khamenehfar A, Li PC.Microfluidic devices for circula-ting tumor cells isolation and subsequent analysis[J]. Curr Pharm Biotechnol,2016,17(9):810-821.
[10] Mohamed H, Murray M, Turner JN, et al.Isolation of tumor cells using size and deformation[J]. J Chromatogr A,2009,1216(47):8289-8295.
[11] Bhagat AA, Hou HW, Li LD, et al.Pinched flow coupled shear-modulated inertial microfluidics for high-throughput rare blood cell separation[J]. Lab Chip,2011,11(11):1870-1878.
[12] Vona G, Sabile A, Louha M, et al.Isolation by size of epi-thelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells[J]. Am J Pathol,2000,156(1):57-63.
[13] Farace F, Massard C, Vimond N, et al.A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas[J]. Br J Cancer,2011,105(6):847-853.
[14] Chen J, Cao SW, Cai Z, et al.Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients[J]. Cancer Biomark,2017,20(4):487-498.
[15] Zhao S, Liu H, Liu Y, et al.miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells[J]. Cancer Lett,2013,333(2):253-260.
[16] Gkountela S, Aceto N.Stem-like features of cancer cells on their way to metastasis[J]. Biol Direct,2016,11:33.
[17] Baccelli I, Schneeweiss A, Riethdorf S, et al.Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay[J]. Nat Biotechnol,2013,31(6):539-544.
[18] Meng S, Tripathy D, Frenkel EP, et al.Circulating tumor cells in patients with breast cancer dormancy[J]. Clin Cancer Res,2004,10(24):8152-8162.
[19] Friedlander TW, Ngo VT, Dong H, et al.Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer[J]. Int J Cancer,2014,134(10):2284-2293.
[20] Pearl ML, Dong H, Zhao Q, et al.iCTC drug resistance (CDR) Testing ex vivo for evaluation of available therapies to treat patients with epithelial ovarian cancer[J]. Gynecol Oncol,2017,147(2):426-432.
[21] Ramirez JM, Fehm T, Orsini M, et al.Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients[J]. Clin Chem,2014,60(1):214-221.
[22] Pantel K, Alix-Panabières C.Functional studies on via-ble circulating tumor cells[J]. Clin Chem,2016,62(2):328-334.
[23] Theodoropoulos PA, Polioudaki H, Agelaki S, et al.Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer[J]. Cancer Lett,2010,288(1):99-106.
[24] Kantara C, O'Connell MR, Luthra G, et al. Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis[J]. Lab Invest,2015,95(1):100-112.
[25] Heitzer E, Auer M, Gasch C, et al.Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing[J]. Cancer Res,2013,73(10):2965-2975.
[26] de Gregorio A, Friedl TWP, Huober J, et al. Discordance in human epidermal growth gactor receptor 2 (HER2) phenotype between primary tumor and circulating tumor cells in women with HER2-negative metastatic breast cancer[J]. JCO Precision Oncology, 2017,1:12.
·专家论坛·
27 精准医学时代遗传性疾病的分子诊断
28 李牛, 王剑
29 (上海交通大学医学院附属上海儿童医学中心分子诊断实验室,上海 200127)
30 摘要:
31 关键词:遗传性疾病; 精准医学; 分子诊断; 高通量测序; 挑战
32 中图分类号:R715.5 文献识别码:A 文章编号:1671-2870(2018)02-0136-05
33 DOI:10.OI:10.16150/j.1671-2870.2018.02.003
34 Title
35 Zuozhe
36 Danwei
37 Abstract
38 keywords
39 [参考文献]
[1] Boycott KM, Rath A, Chong JX, et al.International coo-peration to enable the diagnosis of all rare genetic di-seases[J]. Am J Hum Genet,2017,100(5):695-705.
[2] 钱欣, 罗玉琴, 徐晓姹, 等. 2619例高龄孕妇羊水细胞染色体核型分析[J]. 中华医学遗传学杂志,2009,26(6):712-713.
[3] 张鼎, 胡小梅, 胡爱武. 荧光原位杂交技术及其在遗传学中的应用进展[J]. 中华全科医学,2010,8(6):762-764.
[4] Shen Y, Wu BL.Microarray-based genomic DNA profi-ling technologies in clinical molecular diagnostics[J]. Clin Chem,2009,55(4):659-669.
[5] Hu L, Yao X, Huang H, et al.Clinical significance of germline copy number variation in susceptibility of human diseases[J]. J Genet Genomics,2018,45(1):3-12.
[6] Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification[J]. Nucleic Acids Res,2002,30(12):e57.
[7] Sanger F, Nicklen S, Coulson AR.DNA sequencing with chain-terminating inhibitors[J]. Proc Natl Acad Sci U S A,1977,74(12):5463-5467.
[8] Hehir-Kwa JY, Claustres M, Hastings RJ, et al.Towards a European consensus for reporting incidental findings during clinical NGS testing[J]. Eur J Hum Genet,2015, 23(12):1601-1606.
[9] Meienberg J, Bruggmann R, Oexle K, et al.Clinical sequencing: is WGS the better WES?[J]. Hum Genet,2016,135(3):359-362.
[10] Retterer K, Juusola J, Cho MT, et al.Clinical application of whole-exome sequencing across clinical indications[J]. Genet Med,2016,18(7):696-704.
[11] Caspar SM, Dubacher N, Kopps AM, et al.Clinical sequencing: From raw data to diagnosis with lifetime value[J]. Clin Genet,2018,93(3):508-519.
[12] Byron SA, van Keuren-Jensen KR, Engelthaler DM, et al. Translating RNA sequencing into clinical diagnostics: opportunities and challenges[J]. Nat Rev Genet,2016,17(5):257-271.
[13] Kremer LS, Wortmann SB, Prokisch H. "Transcriptomics": molecular diagnosis of inborn errors of metabolism via RNA-sequencing[J/OL]. Inherit Metab Dis,2018-01-25[2018-03-19]. https://www.ncbi.nlm.nih.gov/pubmed/29372369.
[14] Kimble DC, Lach FP, Gregg SQ, et al.A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families[J]. Hum Mutat,2018,39(2):237-254.
[15] Miller DT, Adam MP, Aradhya S, et al.Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet,2010,86(5):749-764.
[16] Hu X, Li N, Xu Y, et al. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience[J/OL]. Genet Med,2017-11-02[2018-03-19].https://www.ncbi.nlm.nih.gov/pubmed/29095814.
[17] Alfares A, Aloraini T, Subaie LA, et al. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing[J/OL]. Genet Med,2018-03-22[2018-04-09].https://www.ncbi.nlm.nih.gov/pubmed/29565419.
[18] Posey JE, Harel T, Liu P, et al.Resolution of disease phenotypes resulting from multilocus genomic variation[J]. N Engl J Med,2017,376(1):21-31.
[19] Kalia SS, Adelman K, Bale SJ, et al.Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics[J]. Genet Med,2017,19(2):249-255.
[20] Kearney HM, Thorland EC, Brown KK, et al.American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants[J]. Genet Med,2011,13(7):680-685.
[21] Richards S, Aziz N, Bale S, et al.Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med,2015,17(5):405-424.
[22] National Society of Genetic Counselors' Definition Task Force, Resta R, Biesecker BB, et al. A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report[J]. J Genet Couns,2006,15(2):77-83.
[23] Tarailo-Graovac M, Shyr C, Ross CJ, et al.Exome sequencing and the management of neurometabolic disorders[J]. N Engl J Med,2016,374(23):2246-2255.

循环肿瘤细胞检测技术的现状和发展思考

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张祥钦, 江勇. 宏基因组第二代测序技术诊断鹦鹉热衣原体肺炎1例[J]. 诊断学理论与实践, 2022, 21(05): 635-637.
[2]	王也飞, 徐子真, 丁磊, 倪培华, 王学锋. “临床血液学和血液学检验”教学改革的实践探究[J]. 诊断学理论与实践, 2022, 21(05): 659-662.
[3]	陈长强, 孟俊, 金佩佩, 戴菁. 定点医院新型冠状病毒肺炎患者核酸检测工作的实践和探索[J]. 诊断学理论与实践, 2022, 21(02): 143-149.
[4]	娄娇, 蒋玲丽, 王寅, 周靖, 胡晓波, 王青. 医学检验实验室在区域新型冠状病毒核酸检测中的质量监管[J]. 诊断学理论与实践, 2022, 21(02): 174-177.
[5]	孟俊, 金佩佩, 陈长强, 陈韭铭, 范臻佳, 陈诗恺, 戴菁. 紧急转制的新型冠状病毒感染患者定点收治医院检验科的应急转型经验[J]. 诊断学理论与实践, 2022, 21(02): 184-188.
[6]	汤杰, 马龙鑫, 曹青, 林靖生, 陈尔真, 何萍. 基于新一代信息技术的智慧方舱医院建设研究[J]. 诊断学理论与实践, 2022, 21(02): 196-204.
[7]	孟俊, 许啸声, 陆一一, 范臻佳, 蔡刚. 2017年至2020年上海地区妇女宫颈脱落细胞HPV感染亚型调查分析[J]. 诊断学理论与实践, 2021, 20(06): 567-572.
[8]	何碧媛, 周毓青, 姚秉彝, 曹力, 包丽. 中孕期弹性超声成像宫颈机能智能定量分析预测自发性早产的临床应用价值[J]. 诊断学理论与实践, 2021, 20(05): 450-455.
[9]	吴迪, 徐培青, 胡厚佳, 应雅韵, 姜晓星, 丁磊, 王学锋, 倪培华. 医学检验技术专业学生暑期临床实践活动的调研与思考[J]. 诊断学理论与实践, 2021, 20(05): 512-514.
[10]	李海. 慢加急肝衰竭的诊断标准及管理[J]. 诊断学理论与实践, 2021, 20(05): 434-438.
[11]	王也飞, 吴蓓颖, 夏文权, 陈宁, 胡翊群. 高效液相色谱技术联合红细胞参数在血红蛋白病筛查中的应用[J]. 诊断学理论与实践, 2021, 20(03): 271-278.
[12]	梁璆荔, 李莉, 吴洁敏, 陈宁, 刘湘帆, 姜晓星, 倪培华. 线上线下混合实验教学模式在生物化学技术实验课中的实践[J]. 诊断学理论与实践, 2021, 20(01): 109-112.
[13]	郑文芝, 董素芳, 李永莉, 王前, 吴洁. 《临床基础检验学技术》实验教学中翻转课堂联合传统教学法的应用[J]. 诊断学理论与实践, 2021, 20(01): 113-116.
[14]	邓丹琪, 杨滨宾. 皮肤型红斑狼疮的诊治进展[J]. 诊断学理论与实践, 2021, 20(01): 1-7.
[15]	陈福祥, 罗清琼, 徐北惠. 新型冠状病毒感染肺炎的实验诊断[J]. 诊断学理论与实践, 2020, 19(1): 7-10.